Business
-
Generex Biotechnology has reached an agreement with Amarantus BioSciences regarding Generex’s RapidMist buccal aerosol delivery system. The RapidMist device is a modified metered dose inhaler that delivers the aerosol to the lining of the mouth… Read more . . .
-
Rigel Pharmaceuticals has said that it is raising approximately $130.4 million as the result of a stock offering involving 16.3 million new shares. The company says that it expects the offer to close on or… Read more . . .
-
Members of the Committee for Medicinal Products for Human Use (CHMP) have indicated that they would vote against approval of Pharmaxis’s marketing application for Bronchitol as a treatment for cystic fibrosis (CF). The CHMP took… Read more . . .
-
OptiNose has won the Oslo regional competition of the DnB NOR Innovation Award for its nasal drug delivery technology, and the company will compete in the Norwegian national competition in September. The regional award includes… Read more . . .
-
The FDA has announced a shortage of acetylcysteine inhalation solution in the US due to increased demand and manufacturing delays. Acetylcysteine is a mucolytic agent. According to the FDA web site, two manufacturers, Hospira and… Read more . . .
-
One day after issuing a denial (for the second time) regarding rumors of a deal for Nycomed, Takeda has confirmed its acquisition of the Swiss company for €9.6 billion (~$13.7 billion). The deal does not… Read more . . .
-
Regency Therapeutics, a division of Luitpold Pharmaceuticals, and Daiichi-Sankyo, Inc. have announced the launch of Sprix ketorolac tromethamine nasal spray “for the short-term (up to 5 days) management of moderate to moderately severe pain that… Read more . . .
-
GSK and AstraZeneca have announced that the two companies, along with the University of Manchester, are working together to create the Manchester Collaborative Centre for Inflammation Research (MCCIR) to facilitate translational research in inflammatory diseases,… Read more . . .
-
According to reports, Takeda Pharmaceutical is looking to buy Swiss pharma company Nycomed, which manufactures several OINDPs, including the Alvesco ciclesonide MDI and Omnaris ciclesonide nasal spray. Nycomed is also developing a ciclesonide HFA nasal… Read more . . .
-
Five days after its end of review meeting with the FDA on May 4 regarding its Afrezza inhaled insulin, MannKind Corporation held a conference call to update its progress and financial situation. During the call,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden